FGF-2 Polyclonal Antibody
¥680.00
- 产品信息
商品描述
靶点-Target
Cytokeratin 20
反应性
Human,Mouse,Rat,
应用
IHC,WB,IF,ELISA
宿主物种-Host Species
Mouse
同种型-Isotype
IgG2b,Kappa
修饰-Modification
Unmodified
MW(Calculated)
48kD
MW(Observed)
48kD
推荐稀释比
IHC 1:200-1000;WB 1:500-2000;IF 1:100-500;ELISA 1:1000-5000
组成
PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
纯化工艺
Protein G
储存
-15°C to -25°C/1 year(Do not lower than -25°C)
克隆性
Monoclonal
克隆号
ABT044
免疫原
Synthesized peptide derived from human CK20 AA range: 300-424
特异性
The antibody can specifically recognize human CK20 protein, and shows no cross reaction with CK1, 5, 6, 7, 8, 13, 14, 15, 17, 18.
基因名称
KRT20
蛋白名称
Cytokeratin-20
别名
CD20;CK 20;CK-20;CK20;CytokeRatin-20;CytokeRatin20;K1C20_HUMAN;K20;KA20;KeRatin 20;keRatin 20, type I;keRatin 21, Rat, homolog of;KeRatin;KeRatin type I cytoskeletal 20;KeRatin-20;KeRatin20;KRT 20;KRT 21;KRT20;KRT21;MGC35423;OTTHUMP00000164518;Protein IT;type I cytoskeletal 20
Organism-1
Human
基因ID-1
54474
SwissProt-1
P35900
背景
CK20 is a cytokeratin with a molecular weight of 46 kDa, which is mainly expressed in gastrointestinal epithelium, urethral epithelium and Merkel cells. It is mainly used for the diagnosis of gastrointestinal adenocarcinoma, ovarian mucinous tumor, Merkel cell carcinoma and cholangiopancreatic adenocarcinoma. CK20 was negative in squamous cell carcinoma, lung adenocarcinoma, endometrial adenocarcinoma, breast cancer, small cell lung cancer and ovarian non mucinous tumor. It is often used in combination with CK7 and villin to judge the tissue source of adenocarcinoma.
细胞定位
Cytoplasmic, Membranous
